Torthaí cuardaigh - Anton Pozniak
- 1 - 20 toradh as 85 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
HIV Drug Resistance — An Emerging Threat to Epidemic Control de réir Chris Beyrer, Anton Pozniak
Foilsithe / Cruthaithe 2017Artigo -
2
Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break points de réir Alice Raymond, Andrew Hill, Anton Pozniak
Foilsithe / Cruthaithe 2014Artigo -
3
Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs de réir Mariana S. Sousa, Anton Pozniak, Marta Boffito
Foilsithe / Cruthaithe 2008Revisão -
4
Are new antiretroviral treatments increasing the risks of clinical obesity? de réir Andrew Hill, Laura Waters, Anton Pozniak
Foilsithe / Cruthaithe 2019Editorial -
5
Has the time come to abandon efavirenz for first-line antiretroviral therapy? de réir François Raffi, Anton Pozniak, M A Wainberg
Foilsithe / Cruthaithe 2014Revisão -
6
The treatment of tuberculosis in HIV-infected persons de réir Anton Pozniak, Robert F. Miller, Peter L. Ormerod
Foilsithe / Cruthaithe 1999Revisão -
7
Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? de réir Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak
Foilsithe / Cruthaithe 2018Editorial -
8
Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? de réir Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak
Foilsithe / Cruthaithe 2018Artigo -
9
Bacterial Vaginosis, Ethnicity, and the Use of Genital Cleaning Agents: A Case Control Study de réir Sasikala Rajamanoharan, Nicola Low, Simon B. Jones, Anton Pozniak
Foilsithe / Cruthaithe 1999Artigo -
10
Rapidly declining HIV infection in MSM in central London de réir Nneka Nwokolo, Andrew Hill, Alan McOwan, Anton Pozniak
Foilsithe / Cruthaithe 2017Artigo -
11
Gonorrhoea in inner London: results of a cross sectional study de réir Nicola Low, Gavin Daker‐White, David H. Barlow, Anton Pozniak
Foilsithe / Cruthaithe 1997Artigo -
12
Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics de réir Fraser Lewis, G. Hughes, Andrew Rambaut, Anton Pozniak, Andrew Brown
Foilsithe / Cruthaithe 2008Artigo -
13
-
14
Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology de réir Julia del Amo, Adam S. Malin, Anton Pozniak, Kevin M. De Cock
Foilsithe / Cruthaithe 1999Revisão -
15
Clinical management of tuberculosis and HIV-1 co-infection de réir Charlotte Schutz, Graeme Meintjes, Fahad Almajid, Robert J. Wilkinson, Anton Pozniak
Foilsithe / Cruthaithe 2010Artigo -
16
-
17
Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis de réir Christos Michailidis, Anton Pozniak, Sundhiya Mandalia, Sheena Basnayake, Mark Nelson, Brian Gazzard
Foilsithe / Cruthaithe 2005Artigo -
18
Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades de réir Jacob Levi, Alice Raymond, Anton Pozniak, Pietro Vernazza, Philipp Köhler, Andrew Hill
Foilsithe / Cruthaithe 2016Artigo -
19
Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy de réir Nathan Ford, Zara Shubber, Anton Pozniak, Marco Vitória, Meg Doherty, Catherine Kirby, Alexandra Calmy
Foilsithe / Cruthaithe 2015Revisão -
20
Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load de réir Heather Donaghy, Anton Pozniak, Brian Gazzard, Nad A. Qazi, Jill Gilmour, Frances Gotch, Steven Patterson
Foilsithe / Cruthaithe 2001Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Human immunodeficiency virus (HIV)
Viral load
Antiretroviral therapy
Internal medicine
Virology
Immunology
Pharmacology
Biology
Pathology
Family medicine
Intensive care medicine
Adverse effect
Gastroenterology
Efavirenz
Emtricitabine
Genetics
Viral disease
Disease
Dolutegravir
Gene
Ritonavir
Tuberculosis
Virus
Regimen
Tenofovir alafenamide
Drug
Political science
Drug resistance
Environmental health